Abstract
Two distinct physiological processes lead to the development of new blood vessels: vasculogenesis and angiogenesis [reviewed by Risau, 1997]. Whereas vasculogenesis is restricted to embryonic development and consists in the differentiation of mesodermal precursor cells into endothelial cells followed by their organisation into the capillary plexus, angiogenesis is the formation of new capillaries from pre-existing blood vessels and takes place both during prenatal and adult life. Angiogenesis can occur under both physiological and pathological conditions such as during wound healing and solid tumour development. Moreover, intra-arterial angiogenesis is evident in atherosclerotic plaques and in recanalised thrombi [reviewed by Eisenstein, 1991]. The cellular and molecular events that lead to angiogenesis are not as yet fully elucidated but are known to include (i) breakdown of the extracellular matrix and of basement membrane of pre-existing blood vessels; (ii) the migration and proliferation of endothelial cells; (iii) production of extracellular matrix allowing the reconstitution of the basement membrane; (iv) recruitment of pericytes and vascular smooth muscle cells (VSMC) to the newly formed blood vessel.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersson, M., Ostman, A., Westermark, B., Heldin, C-H., 1994. Characterisation of the retention motif in the C-terminal part of the long splice form of platelet-derived growth factor A-chain. J. Biol. Chem. 269: 926–930.
Bachhuber, B.G., Sarembock, I.J., Gimble L.W., and Owens, G.K., 1997. Alpha thrombin induces transforming growth factor beta-1 mRNA and protein in cultred vascular smooth muscle cels via a proteolytically activated recetpro. J. Vasc. Res. 34:41–48.
Bahou, W.F., Coller, B.S., Potter, C.L., Norton K.J., Kutok J.L., and Goligorsky, M.S., 1993. The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J. Clin. Invest. 91: 1405–1413.
Bar-Shavit, R., Benezra, D., Eldor, A., Hy-Am, E., Fenton, J.W., II, and Vlodavsky, I., 1990. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: Nonenzymatic mode of action. Cell Regul. 1: 453–463.
Bar-Shavit, R., Benezra, M., Sabbah, V., Dejana, E., Vlodavsky, I., and Wilner, G.D., 1992. Functional domains in thrombin outside the catalytic site. In: Berliner, L.J., (ed) “Thrombin: structure and function” Plenum Press: NY and London, pp. 315–350
Barger, A., Beeuwkes, R., Lainey, L., Silverman, K., 1984. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N. Eng. J. Med. 310: 175–177.
Belloni, P.N., Carney, D.H., and Nicolson, G.L., 1992. Organ-derived endothelial cells express differential responsiveness to thrombin and other growth factors. Microvasc. Res. 43:20–45.
Benezra, M., Vlodavsky, I., Bar-Shavit, R., 1993. Prothrombin conversion to thrombin by plasminogen activator residing in the subendothelial extracellular matrix. Semin. Thromb. Haemost. 19:405–411.
Benzakour, O., and Kanthou, C., 1996. Cellular and molecular events in atherogenesis: basis for pharmacological and gene therapy approaches to restenosis. Cell Pharmacol. 3:7–22.
Benzakour, O., Kanthou, C., Lupu, F., Dennehy, U., Goodwin, C., Scully, M.F., Kakkar, V.V., and Cooper, D.N., 1955. Prothrombin cleavage by human vascular smooth muscle cells: a potential alternative pathqway to the coagulation cascade. J. Cell Biochem. 59: 514–528.
Berk, B.C., Taubman, M.B., Cragoe, E.J., Fenton, J.W., II, and Greindling K.K., 1991. Thrombin-stimulated events in cultured vascular smooth-muscle cells. Biochem. J. 274: 799–805
Brass, L.F., 1992. Homologous desensitisation of HEL cell thrombin receptors: distinguishable roles for proteolysis and phosphorylation. J. Biol. Chem. 267: 6044–6050.
Brass, L.F., Laposata, F., Banga, H.S., and Rittenhouse, S.E., 1986. Regulation of the phosphoinositide hydrolysis pathway in thrombin-stimulated platelets by a pertussis toxin-sensitive guanine nucleotide-binding protein. J. Biol. Chem. 261: 16833–16847.
Brass, L.F., Pizarro, S., Ahuja, M., Belmonte, E., Stadel, J., and Hoxie, J.A., 1994. Changes in the structure and function of the human thrombin receptor during receptor activation, internalisation, and recycling. J. Biol. Chem. 269: 2943–2952.
Brass, L.F., Vassallo R.R., Belmonte, E., Ahuja, M., Cichowski, K., and Hoxie, J.A., 1992. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptorN terminus. J. Biol. Chem. 267: 13795–13798.
Carney, D.H. 1992. Postclotting cellular effects of thrombin mediated by interactions with high affinity thrombin receptors. In: Berliner, L.J. (ed) “Thrombin: structure and function”. Plenum Press: NY and London, pp. 351–396.
Chen, L.B., and Buchanan, J.M., 1975. Mitogenic activity of blood components. Thrombin and Prothrombin. Proc. Natl. Acad. Sci. USA 72: 131–135.
Clapham, D.E., and Neer, E.J., 1993. New roles for G-protein bg-dimers in transmembrane signalling. Nature 365: 403–406.
Connolly, A., Ishihara, H., Kahn, M., Farese, R.V. Jr., and Coughlin S.R., 1996. Role of thrombin receptor in development and evidence for a second receptor. Nature 381:516–519.
Davies, M.J., Bland, M.J., Hangartner, W.R., Angelini, A., and Thomas, A.C., 1989. Factors influencing the presence of acute coronary thrombi in sudden ischaemic death. Eur. Heart. J. 10: 203–208.
Eisenstein, R., 1991. Angiogenesis in arteries. Pharmacol Ther. 49: 1–19.
Esmon, C.T., 1993. Cell-mediated events that control blood coagulation and vascular injury. Annu. Rev. Cell Biol 9: 1–26.
Garcia, J.G.N., Aschner, J.L., and Malik, A.B., 1992. Regulation of thrombin-induced endothelial barrier dysfunction and prostaglandin synthesis. In: Berliner, L.J., (ed) “Thrombin: structure and fonction” Plenum Press: NY and London, pp. 397–430.
Gerrity, R.G., and Cliff, W.J., 1975. The aortic tunica media of the develooping rat. I. Quantitative stereologic and biochemical analysis. Laborat. Invest. 32: 585–600.
Gerszten, R.E., Chen, J., Ishii, M., Ishii, K., Wang, I., Nanevicz, T., Turck, C.W., Vu, T-K.H., and Coughin S.R., 1994. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 368: 648–651.
Haralabopoulos, G.C., Grant, D.S., Kleinman, H.K., Maragoudakis, M.E., 1997. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Am. J. Physiol. (in press)
Hatton, M.W., Moar, S.L., and Richardson, M., 1989. Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface. Correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed sub endothelium. Am. J. Pathol. 135: 499–508.
Herbert, J-M., Dupuy, E., Laplace, M-C., Zini, J-M., Bar-Shavt, R., and Tobelem G., 1994. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem. J. 303: 227–231.
Herbert, J-M., Lamarche, I., Prabonnaud, V., Dol, F., and Gauthier, T., 1994. Tissue type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J. Biol. Chem. 269: 3076–3080.
Houck, K.A., Ferrara, N., Winer, I., Cachianes, G., Li, B., and Leung, D.W., 1992. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 5: 1806–1814.
Hoxie, J.A., Ahuja, M., Belmonte, E., Pizarro, S., Parton, R., and Brass L.F., 1993. Internalisation and recycling of activated thrombin receptors. J. Biol. Chem. 268: 13756–13763.
Huang, C.L., and Ives, H.E., 1987. Growth inhibition by protein kinase C late in mitogenesis. Nature 329: 849–850.
Hung, D.T., Wong, Y.H., Vu, T-K.H., and Coughlin, S.R., 1992. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J. Biol Chem. 267: 20831–20834.
Ishihara, H., Connolly, A.J., Zeng, D., Kahn, M.L., Zheng Y.W., Timmons, C., Tram, T., and Coughlin S.R., 1997. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386: 502–506.
Ishii, K., Chen J., Ishii, M., Koch, W.J., Freedman, N.J., Lefkowitz, R.J., and Coughlin S.R., 1994. Inhibition of thrombin receptor signalling by a G-protein coupled receptor kinase: functional specificity among G-protein coupled receptor kinases. J. Biol. Chem. 269: 1125–1130.
Ishii, K., Hein, L., Kobilka, B., and Coughlin, S.R., 1993. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J. Biol. Chem. 268: 9780–9786.
Kaetzel, D.M., Coyne, D.W., and Fenstermaker, R.A., 1993. Transcriptional control of the platelet derived growth factor subunit genes. Biofactors 4: 71–81.
Kahan, C., Seuwen, K., Meloche, S., and Pouyssegur, J., 1992. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. J. Biol. Chem. 267: 13369–13375.
Kanse, S.M., Benzakour, O., Kanthou, C., Kost, C., Lijnen, R., and Preissner, K.T., 1997. Urokinase-type plasminogen activator stimulates hyman vascular smooth muscle cell proliferation. Atheroscl. Thromb. Vasc. Biol., (in press).
Kanthou, C., and Benzakour, O., 1995. Cellular effects of thrombin and their signalling pathways. Cell Pharmacol. 2: 293–302.
Kanthou, C., Benzakour, O., Patel, G., Deadman, J., Kakkar, V.V., and Lupu, F., 1995a. Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells. Thromb. Haemost. 74: 1340–1347.
Kanthou, C., Kanse, S.M., Kakkar, V.V., and Benzakour, O., 1996. Involvement of pertussis toxin sensitive and insensitive G proteins in thormbin signalling on cultured human vacular smooth muscle cells. Cell. Signall. 8: 59–66.
Kanthou, C., Kanse, S.M., Newman, P., Kakkar, V.V., and Benzakour, O., 1995b. Structural domains of thormbin involved in the induction of mitogenesis in cultured human vascular smooth muscle cells. Blood Coag. Fibr. 6: 634–642.
Kanthou, C., Parry, G., Wijelath, E., Kakkar, V.V., and Demoliou-Mason, C., 1992. Thrombin-induced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells. FEBS Lett. 314: 134–148.
Ku, P.T., and D’Amore, P.A., 1995. Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. J. Cell Biochem. 58: 328–343.
Li, X.N., Varma, V.K., Parks, J.M., Benza, R.L., Koons J.C., Grammer, JR., Grenett, H., Tabengwa, E.M., and Booyse F.M., 1995. Thombin decreases the urokinase receptor and surface localized fibrinolysis in cultured endothelial cells. Arteroscler. Thromb. 15: 410–419.
Lin, L-L., Wartmann, M., Lin, A.Y., Knopf, J.L, Scih, A.A., and Davis R.J., 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278.
Lombardi, D.M.M., Reidy, M.A., and Schwartz, S.M., 1991. Methodologic considerations important in the accurate quntitation of aortic smooth muscle cell replication in the normal rat. Am. J. Pathol. 138: 441–446.
Magnaldo, I., Pouyssegur, J., and Paris, S., 1988. Thrombin exerts a dual effect on stimulated adenylate cyclase in hamster fibroblasts: an inhibition via a GTP-binding protein and a potentiation via activation of protein kinase C. Biochem. J. 253: 711–719.
Majesky, M.W., Reidy, M.A., Bowen-Pope, D.F., Hart, C.E., Wilcox, J.N., and Schwartz, S.M., 1990. PDGF ligand and receptor gene expression during repair or arterial injury. J. Cell Biol. 111:2149–2158.
Mann, K.G., 1994. Prothrombin and Thrombin. In Colman, R.W., Hirsh, J., Marder, V.J., and Salzman, E.W., (eds): “Haemostasis and Thrombosis: Basic Principles and Clinical Practice”. Lippincott Company: Philadelphia, pp. 184–199.
Maragoudakis, M., E., 1996. The role of thormbinin angiogenesis. In: “Molecular, Celluar and Clinical Aspects of Angiogenesis”‘Ed. Maragoudakis, Plenum Press, pp 115–124.
McNamara, C.A., Sarembock, I.J., Gimple, L.W., Fenton, J.W., II, Coughlin, S.R., and Owens, G.K., 1993. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91: 94–98.
Molloy, C.J., Pawlowski, J.E., Taylor, D.S., Turner, C.E., Weber, H., Peluso, M., and Seiler, S.M., 1996. Thrombin receptor activation elicits rapid protein tyrosine phosphorylatin and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells. J. Clin. Invest. 97: 1173–1183.
Ngaiza, J.R., and Jaffe, E.A., 1991. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacycline production by human endothelial cells. Biochem. Biophys. Res. Commun. 179: 1656–1661.
Noda-Heiny, H., Fujii, S., and Sobel, B.E., 1993. Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Circ. Res. 72: 36–43.
Obberghen-Schilling, E.V., and Pouyssegur, J., 1993. a-Thrombin receptors and growth signalling. Semin. Thromb. Haem. 19: 378–385.
Okada, S.S., Grobmyer, S.R., and Barnathan E.S., 1996. Contrasting effects of plasminogen activators, urokinase receptor and LDL receptor-related protein on smooth muscle cell migration and invation. Arterioscler. Thromb. Vasc. Biol. 16: 1269–1276.
Okazaki, H., Majesky, M.W., Harker, L.A., and Schwartz, S.M., 1992. Regulation of platelet-derived growth factor ligand and receptor gene expression by a-thrombin in vascular smooth muscle cells. Circ. Res. 71: 1285–1293.
Pearson, J.D., 1994. Endothelial cell function and thrombosis. Baillieres Clinical Haematology 7: 441–452.
Pepper, M.S., Montesano, R., Mandriota, S., Orci, L., and Vassalli, J-D., 1996. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migratio and morphogenesis. Enzyme Protein 49: 138–162.
Rade, J.J., Schulick, A.H., Virmani, R., and Dichek, D.A., 1996. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nature Med. 2: 293–298.
Raines, E.W., and Ross, R., 1992. Compartmentalisation of PDGF on extracellular binding sites dependent on exon 6 encoded sequences. J. Cell Biol. 116: 553–543.
Rasmussen, U.B., Vouret-Craviari, V., Jallat, S., Schlesinger, Y., Pages, G., Pavirani, A., Lecocq, J-P., Pouyssegur, J., and Van Obberghen-Schilling, E., 1991. cDNA cloning and expression of a hamster a-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 288: 123–128.
Reuning, U., Little S.P., Dixon, E.P., and Bang, N.U. 1994. Effect of thormbi, the thrombin receptor activation peptide, and other mitogens on vascular smooth muscle cell urokinase receptor mRNA levels. Blood 84: 3700–3708.
Risau, W., 1997. Mechanisms of angiogenesis. Nature 386: 671–674.
Ross, R., 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809.
Scarpati, E.M., and DiCorleto, P.E., 1996. Identification of a thrombin response element in the human platelet-derived growth factor B-chain (c-sis) promoter. J. Biol. Chem. 271: 3025–3032.
Schaeffer, P., Riera, E., Dupuy, E., and Herbert J.M., 1997. Non-proteolytic activation of thro thrombin receptor promotes human umbilical vein endothelial cell growth but not intracellular Ca2+ prostacyclin or permeablility. Biochem. Pharmacol. 53: 487–491.
Sekiya, F., Usui, H., Inoue, K., Fukudome K., Morita, T., 1994. Activation of prothrombin by a novel membrane-associated protease. J. Biol. Chem. 269: 32441–32445.
Scihi, N., and Brookes, M., 1971. Ultrastructure of the blood vessels in the chick allantois and chorioallantois. J. Anat. 109: 1–5.
Shankar, R, de la Motte, C.A., Poptic, E.J., and Dicorletto, P.E., 1994. Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 269: 13936–13941.
Sternberg, J., Redin, W.R., Warner, W.S., and Carney, D.H., 1993. The Role of thrombin and the thrombin receptor activating peptide (TRAP-508) in initiation of tissue repair. Thromb. Haemost. 70: 158–162.
Taipale, J., Koli, K., and Keski-Oja, J., 1992. Release of transforming growth factor-b1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J. Biol. Chem. 267: 25378.
Taparelli, C., Metternich, R., Ehrhardt, C., and Cook, N.S., 1993. Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile. TIPS 14: 366–376.
Trejo, J.A., Connolly, A.J., and Coughlin, S.R., 1996. The cloned thrombin receptor is necessary and sufficient for activtion of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. J. Biol. Chem. 271: 21536–21541.
Tsopanoglou, N.E., Pipili-Synetos, E., and Maragoudakis, M.E., 1993. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiol. 264: C1302–1307.
Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., and Klagsbrun M., 1987. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 84: 2292–2296.
Vouret-Craviari, V., Grall, D., Chambard, J-C., Rasmussen U.B., Pouyssegur, J., and Van Obberghen-Schilling, E., 1995. Post translational and activation-dependent modifications of the G-protein coupled thrombin receptor. J. Biol. Chem. 270: 8367–8372.
Vouret-Craviari, V., Van Obberghen-Schilling, E., Scimeca J-C., Van Obberghen, E., and Pouyssegur J., 1993. Differential activation of p44mapk (ERK1) by a-thrombin and synthetic receptor peptide agonists. Biochem. J. 289: 209–214.
Vouret-Craviari, V., Van Obberghen-Schilling, E., Rasmusse, U.B., Paviran, A., Lecocq, J-P., and Pouyssegur, J., 1992. Synthetic a-thrombin receptor peptides activate G-protein coupled signalling pathways but are unable to induce mitogenesis. Mol. Biol. Cell 3: 95–102.
Vu, T-K.H., Hung, D.T., Wheaton, V.I., and Coughlin, S.R., 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057–1068.
Walters, T.K., Gorog, D.A., and Wood, R.F.M., 1994. Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process. J. Vase. Res. 31: 173–177.
Wang, H.S., Li, F., Runge, M.S., and Chaikof, E.L., 1997. Endothelial cells exhibit differential chemokinetic and mitogenic responsiveness to alpha thormbin. J. Surg. Res. 68: 139–144.
Weiss, R.H., and Maduri, M., 1993. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J. Biol. Chem. 268: 5724–5727.
Weitz, J.I., Hudoba, M., Massel, D., Maraganore, J.M., and Hirsh, J., 1990. Clotbound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin Ill-independent inhibitors. J. Clin. Invest. 86: 385–391.
Wilcox, J.N., Rodriguez, J., Subramanian, R., Ollerenshaw, J., Zhong, C., Hayzer, D.J., Horaist, C., Hanson, S.R., Lumsden A., Salam, T.A., Kelly, A.B., Harker, LA., and Runge, M., 1994. Characterisation of thrombin receptor expression during vascular lesion formation. Circ. Res. 75: 1029–1039.
Wojta, J., Gallicchio, M., Zoellner, H., Hufnagl, P., Last, K., Filonzi, E.L., Binder, B.R., Hamilton, J.A., and McGrath, K., 1993. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle Cells. Thromb. Haemost. 70: 469–474.
Woolkalis, M.J., and Brass, L.F., 1994. Thrombin receptor cleavage and intemalisation in human umbilical endothelial cells. FASEB J.. 8: A 1385.
Zoldhelyi, P., Bichler, J., Owen, W.G., Grill, D.E., Fuster, V., Mruk, J.S., Chesebro, J.H., 1994. Persistent thrombin generation in humans during specific thrombin inhibition with hirudin. Circulation 90: 2671–2678.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kanthou, C., Kakkar, V.V., Benzakour, O. (1998). Cellular and Molecular Effects of Thrombin in the Vascular System. In: Maragoudakis, M.E. (eds) Angiogenesis. NATO ASI Series, vol 298. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9185-3_27
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9185-3_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9187-7
Online ISBN: 978-1-4757-9185-3
eBook Packages: Springer Book Archive